论文部分内容阅读
为观察肝素表面处理人工晶体在糖尿病性白内障手术后的作用。对４５例糖尿病白内障患者行现代囊外白内障摘除，分别植入ＨＳＭ－ＩＯＬ２２眼和ＰＭＭＡ－ＩＯＬ２３眼，对二组术后视力及眼前节反应等进行了回顾性对比分析。结果：二组比较，矫正视力大于０．５者，在术后２周及３个月时差异最显著（Ｐ＜０．０５）；晶体表面纤维蛋白样渗出和色素沉着均在术后２周时差异最显著（Ｐ＜０．０５）；虹膜后粘连在６个月后差异最显著（Ｐ＜０．０５）。结论：ＨＳＭ—ＩＯＬ在术后能减轻糖尿病白内障术后眼前节炎性反应，提高术后视力。
To observe the role of heparin surface treatment of intraocular lens in diabetic cataract surgery. In 45 cases of diabetic cataract patients underwent extracapsular cataract extraction, HSM-IOL22 eyes and PMMA-IOL23 eyes were implanted respectively. The postoperative visual acuity and anterior segment reaction of the two groups were retrospectively analyzed. Results: The corrected visual acuity was greater than 0.5 in the two groups, with the most significant difference at 2 weeks and 3 months after operation (P <0.05). Both fibrinous exudation and pigmentation on the surface of the lens were at 2 (P <0.05). The posterior iridia adhesion was the most significant difference after 6 months (P <0.05). Conclusion: HSM-IOL can reduce anterior eye inflammatory response after cataract surgery and improve postoperative visual acuity.